BOSTON SCIENTIFIC CORPORATION (BSX) FY2026 Q2 Balance Sheet

BOSTON SCIENTIFIC CORPORATION (BSX) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets

45,216,000,000 US dollars

Current assets

7,972,000,000 US dollars

Non-current assets

37,244,000,000 US dollars

Liabilities (calculated)

20,044,000,000 US dollars

Current liabilities

6,428,000,000 US dollars

Non-current liabilities

13,616,000,000 US dollars

Equity

25,172,000,000 US dollars

Noncontrolling interest

242,000,000 US dollars. Included in consolidated equity; this amount is not added again.

Inventories

3,235,000,000 US dollars

Trade accounts receivable, net

3,049,000,000 US dollars

Other current assets

760,000,000 US dollars

Cash and cash equivalents

539,000,000 US dollars

Prepaid income taxes

390,000,000 US dollars

Goodwill

18,640,000,000 US dollars

Other intangible assets, net

6,918,000,000 US dollars

Property, plant and equipment, net

4,126,000,000 US dollars

Deferred tax assets

3,909,000,000 US dollars

Other investments

2,245,000,000 US dollars

Other long-term assets

1,405,000,000 US dollars

Accrued expenses

2,756,000,000 US dollars

Current debt obligations

1,709,000,000 US dollars

Accounts payable

1,231,000,000 US dollars

Other current liabilities

732,000,000 US dollars

Long-term debt

10,915,000,000 US dollars

Other long-term liabilities

2,480,000,000 US dollars

Deferred tax liabilities

221,000,000 US dollars

Additional paid-in capital

21,717,000,000 US dollars

Retained earnings

7,818,000,000 US dollars

Common stock, $0.01 par value - authorized 2,000,000,000 shares - 1,749,917,975 shares issued as of June 30, 2026 and 1,746,290,165 shares issued as of December 31, 2025

17,000,000 US dollars

Preferred stock, $0.01 par value - authorized 50,000,000 shares - 0 shares issued as of June 30, 2026 and December 31, 2025

0 US dollars

Noncontrolling interests

242,000,000 US dollars

Treasury stock, at cost - 303,212,284 shares as of June 30, 2026 and 263,289,848 shares as of December 31, 2025

negative 4,318,000,000 US dollars

Accumulated other comprehensive income (loss), net of tax

negative 304,000,000 US dollars

Chart connections

• Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
• Treasury shares and other negative equity contributions reduce equity.

• The filed current assets lines add up to $7,973.00 M and the current assets total is $7,972.00 M; the $1.00 M difference is within the rounding of the filed amounts.
• The filed non-current assets lines add up to $37,243.00 M and the non-current assets total is $37,244.00 M; the $1.00 M difference is within the rounding of the filed amounts.